We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
-4.46%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$10.5B
AUM Growth
+$4.68B
Cap. Flow
+$4.98B
Cap. Flow %
47.59%
Top 10 Hldgs %
29.39%
Holding
7,240
New
774
Increased
2,864
Reduced
2,421
Closed
823

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$413M
2
MSFT icon
Microsoft
MSFT
+$342M
3
AMZN icon
Amazon
AMZN
+$210M
4
TSLA icon
Tesla
TSLA
+$130M
5
NVDA icon
NVIDIA
NVDA
+$126M

Sector Composition

Rank Sector Weight
1 Technology 30.51%
2 Consumer Discretionary 11.81%
3 Healthcare 9.9%
4 Communication Services 9.49%
5 Financials 9.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZYME icon
3201
Zymeworks
ZYME
$1.78B
$29K ﹤0.01%
4,424
-9,149
-67% -$81.5K
CMBT
3202
CMB.TECH NV
CMBT
$5B
$29K ﹤0.01%
2,721
-9,234
-77% -$91.6K
OKUR
3203
OnKure Therapeutics
OKUR
$162M
$29K ﹤0.01%
980
+856
+690% +$47.9K
PWSC
3204
DELISTED
PowerSchool Holdings, Inc.
PWSC
$29K ﹤0.01%
1,784
-5,271
-75% -$84.4K
AINC
3205
DELISTED
Ashford Inc.
AINC
$29K ﹤0.01%
1,702
+1,500
+743% +$27K
ONCT
3206
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$29K ﹤0.01%
1,047
+329
+46% +$12K
MAXR
3207
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
$29K ﹤0.01%
753
-563
-43% -$17.2K
IVC
3208
DELISTED
Invacare Corporation
IVC
$29K ﹤0.01%
20,424
+13,108
+179% +$28K
FMTX
3209
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
$29K ﹤0.01%
3,099
+1,684
+119% +$17.9K
APPN icon
3210
Appian
APPN
$2.54B
$28K ﹤0.01%
472
-126
-21% -$7.15K
BIRD icon
3211
Smartbird Inc
BIRD
$30.1M
$28K ﹤0.01%
233
-222
-49% -$43.7K
CAAP icon
3212
Corporacion America
CAAP
$6.33B
$28K ﹤0.01%
4,588
+4,434
+2,879% +$25.1K
CELZ icon
3213
Creative Medical Technology
CELZ
$8.04M
$28K ﹤0.01%
+704
New +$15.7K
CENTA icon
3214
Central Garden & Pet Co Class A
CENTA
$2.37B
$28K ﹤0.01%
853
-41
-5% -$1.41K
CNMD icon
3215
CONMED
CNMD
$1.51B
$28K ﹤0.01%
191
-727
-79% -$102K
CXW icon
3216
CoreCivic
CXW
$3.25B
$28K ﹤0.01%
2,483
+639
+35% +$6.25K
GEVO icon
3217
Gevo
GEVO
$418M
$28K ﹤0.01%
6,021
-20,146
-77% -$77K
GMS
3218
DELISTED
GMS Inc
GMS
$28K ﹤0.01%
567
-407
-42% -$21.4K
HFBL icon
3219
Home Federal Bancorp
HFBL
$73M
$28K ﹤0.01%
1,334
+693
+108% +$14.4K
IEFA icon
3220
iShares Core MSCI EAFE ETF
IEFA
$196B
$28K ﹤0.01%
402
+217
+117% +$15.3K
IRBT
3221
DELISTED
iRobot
IRBT
$28K ﹤0.01%
437
-3,170
-88% -$201K
KURA icon
3222
Kura Oncology
KURA
$964M
$28K ﹤0.01%
1,756
-16,196
-90% -$234K
MBUU icon
3223
Malibu Boats
MBUU
$576M
$28K ﹤0.01%
470
-94
-17% -$6.06K
MYFW icon
3224
First Western Financial
MYFW
$310M
$28K ﹤0.01%
902
+768
+573% +$24.9K
OGI
3225
Organigram Holdings
OGI
$173M
$28K ﹤0.01%
4,213
-9,585
-69% -$59.1K

Similar funds

Tower Research Capital (TRC)'s Q1 2022 Portfolio in Review

As of Q1 2022, Tower Research Capital (TRC) held 7,240 positions worth $10.5B, up 81% from $5.78B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Tower Research Capital (TRC) deployed $4.98B of net new capital in Q1 2022, opening 774 new positions and adding to 2,864 existing holdings. Its largest new stake was iShares MSCI USA Value Factor ETF: 132,204 shares worth $13.8M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 25% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $45.1M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2022 buy was iShares MSCI USA Value Factor ETF: 132,204 shares worth $13.8M.
  • Tower Research Capital (TRC) added most to Apple in Q1 2022, an estimated $413M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2022 reduction was iShares Russell 2000 ETF, cutting an estimated $45.1M.
  • Tower Research Capital (TRC) fully exited State Street Technology Select Sector SPDR ETF in Q1 2022, selling an estimated $51.9M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 29% of its $10.5B portfolio in Q1 2022.
  • Tower Research Capital (TRC) opened 774 new positions and closed 823 in Q1 2022.
  • Tower Research Capital (TRC)'s portfolio value rose 81% quarter-over-quarter to $10.5B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2022, filed 12 May 2022.